JAMA Neurology
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, OCTOBER 3, 2022
Media advisory: The full study is linked to this news release.
Free access to the full-text article at the embargo time https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2022.3094?guestAccessKey=ce960504-fcba-4535-a64f-2dc656338a60&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=100322
Citation
Alothman D, Card T, Lewis S, Tyrrell E, Fogarty AW, Marshall CR. Risk of Suicide After Dementia Diagnosis. JAMA Neurol. Published online October 03, 2022. doi:10.1001/jamaneurol.2022.3094
About The Study: The results of this nationally representative study including 594,000 persons in England suggest that there was an increased risk of suicide associated with dementia in patients diagnosed before the age of 65, those with a recent dementia diagnosis (within 3 months), and those with existing diagnoses of psychiatric comorbidities. In particular, there was an association between increased suicide risk in patients who were diagnosed younger than 65 years in the 3-month post-diagnostic period. Diagnostic and management services for dementia, in both primary and secondary care settings, should target suicide risk assessment to the identified high-risk groups.
Authors: Danah Alothman, B.M.B.Ch., M.P.H., of the University of Nottingham in Nottingham, United Kingdom, is the corresponding authors.
(doi:10.1001/jamaneurol.2022.3094)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
